Sabarinath(N)Venniyil RadhakrishnaMD

PubMed

• Adverse effects and non-relapse mortality of BCMA directed T cell therapies in multiple myeloma: an FAERS database study.
  Zimu Gong, Godsfavour Umoru, Jorge Monge, Nishi Shah, Ghulam Rehman Mohyuddin, Sabarinath Venniyil Radhakrishnan, Rajshekhar Chakraborty, Leo Rasche, Carolina Schinke,...> ;Blood Cancer Journal. 2024 Mar 5
• Autologous stem cell boost improves persistent immune effector cell associated hematotoxicity following BCMA directed chimeric antigen receptor T (CAR T) cell therapy ...
  Mohan, M., Szabo, A., Patwari, A., Esselmann, J., Patel, T., Bachu, R., Rein, L., Janardan, A., Bhatlapenumarthi, V., Annyapu, E., Skoog, C., Goff, A., Hadidi, S., Rad...> ;Bone Marrow Transplantation. 2024 Feb 15
• Restricting CAR T Cell Trafficking Expands Targetable Antigen Space.
  Morales, E., Dietze, K., Baker, J., Wang, A., Avila, S., Iglesias, F., Mause, E., Olson, M., Sun, W., Rosati, E., Chidester, S., Iraguha, T., Fan, X., Luetkens, T., Ra...> ;Biorxiv. 2024 Feb 11
• 1 citations
  Blood and marrow transplant within 4 weeks of SARS-CoV-2 infection is associated with increased risk of mortality: a National COVID Cohort Collaborative (N3C) Study.
  Meera Mohan, Anai Kothari, Nathaniel Verhagen, Aditya Shreenivas, Sabarinath Venniyil Radhakrishnan, Binod Dhakal, Carlos Figueroa-Castro, Saurabh Chhabra, Siegfried J...> ;Bone Marrow Transplantation. 2024 Jan 1
• 9 citations
  The changing spectrum of infection with BCMA and GPRC5D targeting bispecific antibody (bsAb) therapy in patients with relapsed refractory multiple myeloma.
  Lindsay Hammons, Aniko Szabo, Abhishek Janardan, Vineel Bhatlapenumarthi, Evanka Annyapu, Binod Dhakal, Samer Al Hadidi, Sabarinath Venniyil Radhakrishnan, Ravi Narra,...> ;Haematologica. 2024 Mar 1
• 2 citations
  Systematic single amino acid affinity tuning of CD229 CAR T cells retains efficacy against multiple myeloma and eliminates on-target off-tumor toxicity.
  Erica R Vander Mause, Jillian M Baker, Kenneth A Dietze, Sabarinath V Radhakrishnan, Thierry Iraguha, Destiny Omili, Patricia Davis, Sadie L Chidester, Katarzyna Modze...> ;Science Translational Medicine. 2023 Jul 19
• 13 citations
  Clinical outcome of patients with relapsed refractory multiple myeloma listed for BCMA directed commercial CAR-T therapy.
  Al Hadidi, S., Szabo, A., Esselmann, J., Hammons, L., Hussain, M., Ogunsesan, Y., Thalambedu, N., Khan, F., Sethi, J., Janardan, A., Radhakrishnan, S., Thanendrarajan,...> ;Bone Marrow Transplantation. 2023 Apr 1
• 5 citations
  Corneal toxicity with belantamab mafodotin: Multi-institutional real-life experience.
  Meera Mohan, Lisa E Rein, Nishanth Thalambedu, Yetunde Ogunsesan, Munawwar Hussain, Jaskirat Sethi, Fatima Khan, Sravani Gundarlapalli, Lakshmi Yarlagadda, Binod Dhaka...> ;American Journal of Hematology. 2022 Dec 1
• 3 citations
  Clinical efficacy of sequencing CD38 targeting monoclonal antibodies in relapsed refractory multiple myeloma: A multi-institutional experience.
  Meera Mohan, Melody Renee Becnel, Urvi A Shah, Huaying Dong, Sravani Gundarlapalli, Timothy Peterson, Jennifer S Orozco, Sandra Horowitz, Saurabh Chhabra, Binod Dhakal...> ;American Journal of Hematology. 2022 Jul 1
• 38 citations
  Low-affinity CAR T cells exhibit reduced trogocytosis, preventing rapid antigen loss, and increasing CAR T cell expansion.
  Michael L Olson, Erica R Vander Mause, Sabarinath V Radhakrishnan, Joshua D Brody, Aaron P Rapoport, Alana L Welm, Djordje Atanackovic, Tim Luetkens> ;Leukemia. 2022 Jul 1
• 26 citations
  Risk of infections with B-cell maturation antigen-directed immunotherapy in multiple myeloma.
  Meera Mohan, Sneha Nagavally, Binod Dhakal, Sabarinath Venniyil Radhakrishnan, Saurabh Chhabra, Anita D'Souza, Parameswaran Hari> ;Blood Advances. 2022 Apr 26
• 36 citations
  CD229 CAR T cells eliminate multiple myeloma and tumor propagating cells without fratricide
  Sabarinath Venniyil Radhakrishnan, Tim Luetkens, Sandra D. Scherer, Patricia Davis, Erica R. Vander Mause, Michael Olson, Sara Yousef, Jens Panse, Yasmina Noubia Abdic...> ;Nature Communications. 2020 Feb 7
• 30 citations
  In vivo vaccination effect in multiple myeloma patients treated with the monoclonal antibody isatuximab
  Djordje Atanackovic, Sara Yousef, Christa Shorter, Srinivas K. Tantravahi, Mary Steinbach, Fiorella Iglesias, Douglas W. Sborov, Sabarinath Venniyil Radhakrishnan, Mar...> ;Leukemia. 2020 Jan 1
• A Phase 1 Study of Intravenous Busulfan as a Conditioning Regimen for Multiple Myeloma.
  Sabarinath Venniyil Radhakrishnan, Michael Boyer, Catherine M.T. Sherwin, Maurizio Zangari, Guido J Tricot> ;Cell Transplantation. 2019 Oct 16
• 2 citations
  Elotuzumab as a novel anti-myeloma immunotherapy
  Sabarinath Venniyil Radhakrishnan, Neelam Bhardwaj, Mary Steinbach, Janet Weidner, Tim Luetkens, Djordje Atanackovic> ;Human Vaccines & Immunotherapeutics. 2017 Jun 12
• 18 citations
  Novel anti-myeloma immunotherapies targeting the SLAM family of receptors
  Sabarinath Venniyil Radhakrishnan, Neelam Bhardwaj, Tim Luetkens, Djordje Atanackovic> ;Oncoimmunology. 2017 May 8
• 8 citations
  Oscillating expression of interleukin-16 in multiple myeloma is associated with proliferation, clonogenic growth, and PI3K/NFKB/MAPK activation.
  Julia Templin, Djordje Atanackovic, Daniel Hasche, Sabarinath Venniyil Radhakrishnan, Tim Luetkens> ;Oncotarget. 2017 Apr 30
• 28 citations
  Immunotherapies targeting CD38 in Multiple Myeloma
  Djordje Atanackovic, Mary Steinbach, Sabarinath Venniyil Radhakrishnan, Tim Luetkens> ;Oncoimmunology. 2016 Aug 5
• 48 citations
  Chimeric Antigen Receptor (CAR) therapy for multiple myeloma.
  Djordje Atanackovic, Sabarinath Venniyil Radhakrishnan, Neelam Bhardwaj, Tim Luetkens> ;British Journal of Haematology. 2016 Mar 1
• 3 citations
  A Call to Arms: a Critical Need for Interventions to Limit Pulmonary Toxicity in the Stem Cell Transplantation Patient Population
  Sabarinath Venniyil Radhakrishnan, Gerhard C. Hildebrandt> ;Current Hematologic Malignancy Reports. 2015 Feb 8
• 12 citations
  Preventive Azithromycin Treatment Reduces Noninfectious Lung Injury and Acute Graft-versus-Host Disease in a Murine Model of Allogeneic Hematopoietic Cell Transplantation
  Sabarinath Venniyil Radhakrishnan, Senthilnathan Palaniyandi, Gunnar Mueller, Sandra Miklos, Max Hager, Elena Spacenko, Fridrik Karlsson, Elisabeth Huber, Nicolai A. K...> ;Biology of Blood and Marrow Transplantation. 2015 Jan 1
• 189 citations
  Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage
  Lukas Schwab, Luise Goroncy, Senthilnathan Palaniyandi, Sanjivan Gautam, Antigoni Triantafyllopoulou, Attila Mócsai, Wilfried Reichardt, Fridrik Karlsson, Sabarinath V...> ;Nature Medicine. 2014 Jun 1
• Join now to see all